1. Identification of MRC2 and CD209 receptors as targets for photodynamic therapy of retinoblastoma using mesoporous silica nanoparticles1. Issue 92 (8th October 2015) Authors: Gallud, A.; Warther, D.; Maynadier, M.; Sefta, M.; Poyer, F.; Thomas, C. D.; Rouxel, C.; Mongin, O.; Blanchard-Desce, M.; Morère, A.; Raehm, L.; Maillard, P.; Durand, J. O.; Garcia, M.; Gary-Bobo, M. Journal: RSC advances Issue: Volume 5:Issue 92(2015) Page Start: 75167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗